To provide a method for determining presence or absence of medullary thyroid cancer, which can specifically detect medullary thyroid cancer.
A method for determining presence or absence of medullary thyroid cancer uses a method having a process (a) for detecting expression of a splicing variant of CEACAM4 gene such as a cDNA composed of a specific base sequence in a sample for determination or the splicing variant such as a protein composed of an amino acid sequence encoded by the base sequence, etc., and a process (b) for evaluating that possibility of a sample donor for determination having medullary thyroid cancer is high when the expression of the splicing variant of CEACAM4 gene or a protein encoded by the splicing variant is detected in the process (a).
MOCHIZUKI TORU
HATAKEYAMA KEIICHI
YAMAGUCHI KEN
| WO2003095622A2 | 2003-11-20 |
JPN6017000608; ｄａｔａｂａｓｅ ＧｅｎＢａｎｋ , 20080724, ＡＫ２９８７０１
JPN6017000609; 日本内科学会雑誌 ｖｏｌ．８６ ｎｏ．７, 1997, ｐｐ．９４-１００
Seiji Ozawa
Yusaku Tokai
Makoto Horiuchi
Next Patent: GENETICALLY MODIFIED VARIANT OF RHODOCOCCUS BACTERIUM, AND METHOD FOR PRODUCING THE SAME